BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34072676)

  • 1. Multi-Institutional Retrospective Analysis of Carbon-Ion Radiotherapy for Patients with Locally Advanced Adenocarcinoma of the Uterine Cervix.
    Okonogi N; Ando K; Murata K; Wakatsuki M; Noda SE; Irie D; Tsuji H; Shozu M; Ohno T
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    Kobayashi N; Oike T; Ando K; Murata K; Tamaki T; Noda SE; Kogure K; Nobusawa S; Oyama T; Ohno T
    J Med Case Rep; 2024 May; 18(1):228. PubMed ID: 38720351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysis.
    Okonogi N; Wakatsuki M; Kato S; Murata H; Kiyohara H; Karasawa K; Ohno T; Tsuji H; Nakano T; Shozu M;
    Cancer Med; 2020 Feb; 9(4):1400-1408. PubMed ID: 31891228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study.
    Okonogi N; Usui H; Murata K; Hori M; Kurokawa T; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Hasegawa S; Yamada S; Hanaoka H; Shozu M; Tsuji H
    BMJ Open; 2022 Mar; 12(3):e056424. PubMed ID: 35236732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary result of combined treatment with scanning carbon-ion radiotherapy and image-guided brachytherapy for locally advanced cervical adenocarcinoma.
    Tsuchida K; Yoshida D; Shima S; Kusunoki T; Takayama Y; Koge H; Kano K; Takakusagi Y; Mizoguchi N; Kamada T; Kusano Y; Kato H; Katoh H
    J Radiat Res; 2024 Jun; ():. PubMed ID: 38842119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of carbon ion radiotherapy with concurrent chemotherapy for locally advanced uterine cervical adenocarcinoma in a phase 1/2 clinical trial (Protocol 1001).
    Okonogi N; Wakatsuki M; Kato S; Karasawa K; Kiyohara H; Shiba S; Kobayashi D; Nakano T; Kamada T; Shozu M;
    Cancer Med; 2018 Feb; 7(2):351-359. PubMed ID: 29341491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase Ib Study of Durvalumab (MEDI4736) in Combination with Carbon-Ion Radiotherapy and Weekly Cisplatin for Patients with Locally Advanced Cervical Cancer (DECISION Study): The Early Safety and Efficacy Results.
    Okonogi N; Murata K; Yamada S; Habu Y; Hori M; Kurokawa T; Inaba Y; Fujiwara T; Fujii Y; Hanawa M; Kawasaki Y; Hattori Y; Suzuki K; Tsuyuki K; Wakatsuki M; Koto M; Hasegawa S; Ishikawa H; Hanaoka H; Shozu M; Tsuji H; Usui H
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma.
    Iijima M; Okonogi N; Nakajima NI; Morokoshi Y; Kanda H; Yamada T; Kobayashi Y; Banno K; Wakatsuki M; Yamada S; Kamada T; Aoki D; Hasegawa S
    J Gynecol Oncol; 2020 Mar; 31(2):e19. PubMed ID: 31912675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes of carbon-ion radiotherapy for locally advanced non-small-cell lung cancer.
    Hayashi K; Yamamoto N; Nakajima M; Nomoto A; Tsuji H; Ogawa K; Kamada T
    Cancer Sci; 2019 Feb; 110(2):734-741. PubMed ID: 30467928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG).
    Okano N; Suefuji H; Nakajima M; Tokumaru S; Kubo N; Yoshida D; Suzuki O; Ishikawa H; Satouchi M; Nakayama H; Shioyama Y
    J Radiat Res; 2023 Jun; 64(Supplement_1):i2-i7. PubMed ID: 37036751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer.
    Hayashi K; Yamamoto N; Karube M; Nakajima M; Matsufuji N; Tsuji H; Ogawa K; Kamada T
    Radiat Oncol; 2017 May; 12(1):91. PubMed ID: 28558766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 1/2 Study of Carbon Ion Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Uterine Cervical Squamous Cell Carcinoma (Protocol 1302).
    Okonogi N; Wakatsuki M; Kato S; Karasawa K; Miyasaka Y; Murata H; Nakano T; Kamada T; Shozu M;
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):631-639. PubMed ID: 30825494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-ion radiotherapy boost with standard dose proton radiation for incomplete-resected high-grade glioma: a phase 1 study.
    Qiu X; Gao J; Yang J; Hu J; Hu W; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1193. PubMed ID: 36544659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer.
    Okamoto M; Shiba S; Okazaki S; Miyasaka Y; Shibuya K; Kiyohara H; Ohno T
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Treatment Time on Chemoradiotherapy in Locally Advanced Cervical Carcinoma.
    Pathy S; Kumar L; Pandey RM; Upadhyay A; Roy S; Dadhwal V; Madan R; Chander S
    Asian Pac J Cancer Prev; 2015; 16(12):5075-9. PubMed ID: 26163644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.